The ALMA multidimensional group intervention improves cognitive function in women with breast cancer undergoing active oncological treatment.
This protocol describes a randomized controlled trial evaluating the ALMA intervention (two 120 min face-to-face sessions/week for four months) in 63 women with breast cancer. The primary outcome is objective global cognitive performance measured by the Montreal Cognitive Assessment, with secondary outcomes including perceived cognitive function, sleep quality, and functional autonomy.
This article is automatically generated from the structured evidence profile behind the claim above. Scores reflect the quality and quantity of available research, not clinical advice.
The ALMA multidimensional group intervention improves cognitive function in women with breast cancer undergoing active oncological treatment. The current body of evidence comprises 1 study, including 1 randomized controlled trial. EvidenceHub rates the overall confidence at 42/100 (low).
The Claim
The ALMA multidimensional group intervention improves cognitive function in women with breast cancer undergoing active oncological treatment.
This conclusion is most relevant to: Women with breast cancer undergoing active oncological treatment.
What the Research Shows
The conclusion draws on 1 linked study. Highlights from the cited literature:
- ▸Effectiveness of the ALMA Intervention on Cognitive Function in Women with Breast Cancer: Protocol for a Randomized Controlled Trial. (Journal of clinical medicine, 2026) —
How It Works
The proposed biological pathway:
- ▸Psychoeducation addresses cognitive concerns and coping strategies
- ▸Targeted cognitive stimulation exercises specific cognitive domains
- ▸Group feedback provides social support and reinforcement
- ▸Result: Improved cognitive function and related outcomes
Who Might Benefit
Evidence fit by population:
- ▸Women with breast cancer undergoing active oncological treatment
Recommended Dose
N/A
Limitations & Caveats
Important context when interpreting this evidence:
- ▸Single-centre design may limit generalizability
- ▸Results are expected and not yet available; protocol only
- ▸Small sample size (n=63) may reduce statistical power
Frequently Asked Questions
What is the ALMA intervention?▼
ALMA stands for Playful Attention and Active Memory, a multidimensional group intervention combining psychoeducation, cognitive stimulation, and group feedback delivered in two 120-minute sessions per week for four months.
Who is eligible for this study?▼
Women with breast cancer currently undergoing active oncological treatment at the University Healthcare Complex of Salamanca, Spain.
What is the primary outcome measured?▼
The primary outcome is objective global cognitive performance assessed by the Montreal Cognitive Assessment (MoCA).
How does this trial compare ALMA to other interventions?▼
The trial compares ALMA to a health education control group and an individual non-tailored cognitive training group in a three-arm randomized design.
References
- 1.Teixeira de Sousa SR, Sánchez-Rodríguez JL, Sánchez-Gil A, Sánchez-Gómez C, Arroyo-Garrapucho N, Fonseca-Sánchez E, Figuero-Pérez L, Sánchez-González JL, Fernández-Rodríguez EJ. “Effectiveness of the ALMA Intervention on Cognitive Function in Women with Breast Cancer: Protocol for a Randomized Controlled Trial..” Journal of clinical medicine, 2026. PMID: 42452339 DOI: 10.3390/jcm15134876